Evidence map›Paper›PMID 9696874›Full record

ArticleJournal of virology1998

Mutations in the primer grip of human immunodeficiency virus type 1 reverse transcriptase impair proviral DNA synthesis and virion maturation.

Q Yu, M Ottmann, C Pechoux, S Le Grice, J L Darlix

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Q YuLaboRetro, Unité de Virologie Humaine INSERM U412, Ecole Normale Supérieure de Lyon, 69364 Lyon Cedex 07, France.
M Ottmann
C Pechoux
S Le Grice
J L Darlix
École Normale Supérieure de Lyon · FRInserm · FRCase Western Reserve University · US

Funding

BIOCHEMICAL EVALUATION OF RT-TEMPLATE-PRIMER/COMPLEXESR01GM052263 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI BARKLEY, MARY D · 1994 to 2001
$505k
NIGMS NIH HHS GM 52263
6 · The paper itself

Abstract

This report describes the effects of mutating highly conserved residues in the primer grip domain of human immunodeficiency virus type 1 reverse transcriptase (RT) on virus formation and infectivity. Among a series of RT mutant viruses, three (M230A, L234D, and W239A) were found to be noninfectious or very poorly infectious. Our data indicate that these mutations in RT caused severe defects in proviral DNA synthesis. Interestingly, assembly and maturation of mutant virus M230A were similar to those of the wild type, while mutants L234D and W239A showed impaired maturation. The immature morphology of RT mutants L234D and W239A is due at least in part to premature cleavage of the gag-pol precursor, prior to virion budding, indicating that intracellular stability of Pr160(gag-pol) is of key importance during virus assembly.

Indexed as

MutationVirus AssemblyAmino Acid SequenceDNA, Viralgag Gene Products, Human Immunodeficiency VirusGene Products, gagHeLa CellsHIV-1HIV Reverse TranscriptaseHumansMolecular Sequence Datapol Gene Products, Human Immunodeficiency VirusProtein PrecursorsProvirusesVirionDNA, Viralgag Gene Products, Human Immunodeficiency VirusGene Products, gagHIV Reverse Transcriptasepol Gene Products, Human Immunodeficiency Viruspr160 gag-pol precursor protein, Human immunodeficiency virus 1Protein Precursors

Identifiers

PMID9696874
PMCPMC110040
OpenAlexW1873555895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.